American Heart Journal
Volume 152, Issue 3 , Pages 454.e1-454.e8 , September 2006

National evaluation of adherence to β-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance

  • Judith M. Kramer, MD, MS

      Affiliations

    • Duke Center for Education and Research on Therapeutics, Duke University Medical Center, Durham, NC
    • Corresponding Author InformationReprint requests: Judith M. Kramer, MD, MS, Duke Center for Education and Research on Therapeutics, Duke University Medical Center, PO Box 17969, Durham, NC 27715.
    • ,
  • Bradley Hammill, MA

      Affiliations

    • Duke Center for Education and Research on Therapeutics, Duke University Medical Center, Durham, NC
    • ,
  • Kevin J. Anstrom, PhD

      Affiliations

    • Duke Center for Education and Research on Therapeutics, Duke University Medical Center, Durham, NC
    • ,
  • Donald Fetterolf, MD, MBA

      Affiliations

    • Council for Affordable Quality Healthcare, Washington, DC
    • ,
  • Richard Snyder, MD

      Affiliations

    • Council for Affordable Quality Healthcare, Washington, DC
    • ,
  • John P. Charde, MD

      Affiliations

    • Council for Affordable Quality Healthcare, Washington, DC
    • ,
  • Barbara S. Hoffman, PA-C, MBA

      Affiliations

    • Council for Affordable Quality Healthcare, Washington, DC
    • ,
  • Nancy Allen LaPointe, PharmD

      Affiliations

    • Duke Center for Education and Research on Therapeutics, Duke University Medical Center, Durham, NC
    • ,
  • Eric Peterson, MD, MPH

      Affiliations

    • Duke Center for Education and Research on Therapeutics, Duke University Medical Center, Durham, NC

Received 30 January 2006 ,Accepted 17 February 2006.

  • Image Result

    National adherence by cumulative time intervals.

    National adherence by cumulative time intervals.

  • Image Result

    National adherence for cumulative time intervals by health plan product for patients aged 35 to 64 (A) and ≥65 years (B).

    National adherence for cumulative time intervals by health plan product for patients aged 35 to 64 (A) and ≥65 years (B).

  • Image Result

    Adherence over 360 days by region and product. Kruskall-Wallis test: All patients: P < 0.0001; Medicare + Choice: P = 0.04.

    Adherence over 360 days by region and product. Kruskall-Wallis test: All patients: P < 0.0001; Medicare + Choice: P = 0.04.

 Duke investigators are supported in part by grant HS010548 from the Agency for Healthcare Research and Quality, Rockville, Md.

 Funding/Support: Participating health plans contributed personnel time for work groups (listed in Appendix B) and for collection and reporting of data. The Council for Affordable Quality Healthcare (CAQH) contracted with PricewaterhouseCoopers to aggregate de-identified data submitted by health plans and to provide feedback to the plans on the quality of data. The CAQH also provided an honorarium to Duke University for its investigators' time in analyzing and interpreting the aggregated data and preparing the manuscript.

 Role of the Sponsor: CAQH provided a project manager to support the CAQH Cardiac and Measurement Work Groups. Final decisions on study design and technical specifications were made by the CAQH Cardiac and Measurement Work Groups. The CAQH allowed Duke investigators full independence in the analysis and interpretation of the data. The manuscript was prepared by Duke investigators. Contributing authors provided review and approval.

 Guest editor of this manuscript is Deepak L. Bhatt, MD.

PII: S0002-8703(06)00169-4

doi: 10.1016/j.ahj.2006.02.030

American Heart Journal
Volume 152, Issue 3 , Pages 454.e1-454.e8 , September 2006

Article Tools

* Image Usage & Resolution